Categories: CHF

Sequana Medical announces FDA clearance of IND application for DSR(R) 2.0 for treatment of congestive heart failure

Oliver Godje, Chief Medical Officer of Sequana Medical, commented:”We are delighted to obtain clearance of the IND for our DSR 2.0 product andare ready to commence the MOJAVE study in US patients with …
Read Full Story at source (may require registration)

Business Editor

Share
Published by
Business Editor

Recent Posts

Australian Dollar Speculative Net Positions Improve, But Remain in the Negative

The latest data release from the Commodity Futures Trading Commission (CFTC) reveals a marginal improvement…

6 hours ago

Swiss Franc Speculative Positions Narrow as Traders Eye Future Direction

Traders and economists are taking a keen interest in the latest update from the Commodity…

6 hours ago

CFTC Reports Decline in Speculative Net Positions for Mexican Peso

In an updated report dated April 18, 2025, the Commodity Futures Trading Commission (CFTC) has…

6 hours ago

Speculative Net Positions in CFTC Wheat Futures Narrow as Traders Adjust Bets

The Commodity Futures Trading Commission (CFTC) has reported an improvement in wheat speculative net positions…

6 hours ago

Silver Speculative Net Positions Decline in Latest CFTC Data

In its latest release, the U.S. Commodity Futures Trading Commission (CFTC) reported a decrease in…

6 hours ago

How High Will Bitcoin Go? A Deep Dive Into Market Trends

Amid market turmoil, will Bitcoin keep going up or is it due for another correction?…

6 hours ago

This website uses cookies.